Insider Selling: American Well (NYSE:AMWL) Insider Sells $109,746.00 in Stock

American Well Corporation (NYSE:AMWL) insider Dmitry Zamansky sold 8,442 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $13.00, for a total value of $109,746.00. Following the sale, the insider owned 224,178 shares of the company’s stock, valued at $2,914,314. This represents a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

American Well Price Performance

Shares of American Well stock opened at $12.65 on Thursday. The business’s 50 day simple moving average is $12.63 and its two-hundred day simple moving average is $9.65. The stock has a market capitalization of $209.37 million, a P/E ratio of -2.65 and a beta of 1.67. American Well Corporation has a one year low of $3.71 and a one year high of $14.19.

American Well (NYSE:AMWL) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.86) by $0.27. American Well had a negative return on equity of 30.12% and a negative net margin of 35.75%.The firm had revenue of $52.05 million during the quarter, compared to the consensus estimate of $49.87 million. Sell-side analysts expect that American Well Corporation will post -2.56 earnings per share for the current fiscal year.

Institutional Investors Weigh In On American Well

An institutional investor recently raised its stake in American Well stock. Senvest Management LLC boosted its stake in American Well Corporation (NYSE:AMWL) by 213.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,136,558 shares of the company’s stock after buying an additional 773,834 shares during the period. Senvest Management LLC owned 6.87% of American Well worth $5,978,000 at the end of the most recent reporting period. 56.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AMWL. Needham & Company LLC reissued a “hold” rating on shares of American Well in a report on Wednesday, August 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of American Well in a report on Friday, July 17th. Truist Financial set a $12.00 target price on American Well and gave the stock a “hold” rating in a research note on Thursday, August 13th. Finally, Wells Fargo & Company boosted their price target on American Well from $9.00 to $16.00 and gave the company an “overweight” rating in a report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, American Well has an average rating of “Hold” and an average price target of $9.50.

American Well Company Profile

American Well Corporation, doing business as Amwell, is a digital health company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care, specialty care and chronic-condition management.

Amwell also provides software and infrastructure that enable health systems, health plans, employers and government organizations to offer and manage digital healthcare programs.